Skip to main content
Clinical Trials/JPRN-C000000137
JPRN-C000000137
Completed
Phase 4

Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE) - HOMED-BP Study

HOMED-BP Study Group0 sites9,000 target enrollmentSeptember 9, 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
HOMED-BP Study Group
Enrollment
9000
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2005
End Date
April 1, 2010
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HOMED-BP Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Severe hypertension (either Home BP \>\= 180/120 mmHg or Clinic BP \>\= 220/125 mmHg), pure systolic hypertension (Home systolic BP \>\= 135 mmHg and Home diastolic BP \=\< 65 mmHg), pure diastolic hypertension (Home systolic BP \=\< 110 mmHg and Home diastolic BP \>\= 85 mmHg), or contra\-indication to treatment with Ca\-A, ACE\-I, ARB.

Outcomes

Primary Outcomes

Not specified

Similar Trials